Human monoclonal antibodies to immunoglobulin superfamily receptor translocation- associated-3, -4 and -5 molecules as potential therapeutic agents for B-cell malignancies

Author：  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.11, 2006-11, pp. : 1593-1600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

By Bornstein Gadi   Quéva Christophe   Tabrizi Mohammad   Abbema Anne   Chavez Carlos   Wang Ping   Foord Orit   Ahluwalia Kiran   Laing Naomi   Raja Sandhya   Wen Shenghua   Green Larry   Yang Xiaodong   Webster Carl   Stewart Ross   Blakey David  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 561-574

Springer Publishing Company

Access to resources Recommend Favorite

Idiotype Vaccines for Human B-Cell Malignancies

By  

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 300-307

Bentham Science Publishers

Access to resources Recommend Favorite

To make antibodies or not: signaling by the B-cell antigen receptor

By Gold M.R.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 7, 2002-07 ,pp. : 316-324

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

By Korycka-Wołowiec Anna   Robak Tadeusz  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1455-1468

Informa Healthcare

Access to resources Recommend Favorite

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 790-800

Bentham Science Publishers

Access to resources Recommend Favorite